%0 Journal Article
%T 23价肺炎疫苗联合流感疫苗接种对慢性阻塞性肺疾病影响的Meta分析
Meta-Analysis of the Effect of 23 Valent Pneumonic Vaccine Combined with Influenza Vaccine on Chronic Obstructive Pulmonary Disease
%A 李钰婵
%A 戚萌
%A 梁楠
%A 杨淑梅
%A 兀威
%A 张薇
%J Advances in Clinical Medicine
%P 6731-6739
%@ 2161-8720
%D 2022
%I Hans Publishing
%R 10.12677/ACM.2022.127971
%X 目的:比较23价肺炎球菌多糖疫苗、流感疫苗联合接种和常规治疗对慢性阻塞性肺疾病(Chronic Obstructive Pulmonary Disease COPD)患者的临床防治效果。方法:检索时间从各数据库建库时间至2022年6月的中英文数据库。阅读相关文献,根据纳入与排除标准筛选文献提取资料,对文献质量进行评价,采用RevMan5.4软件进行分析。结果:共纳入12篇文献,1416个研究对象,其中干预组占699个,对照组717个。进行荟萃分析后结果显示,23价肺炎球菌疫苗联合流感疫苗可缩短COPD患者平均住院天数(WMD = ?4.35, 95% CI = ?4.50~?4.21, P < 0.00001)、减少COPD急性发作次数(WMD = ?4.31, 95% CI = ?4.46~?4.17, P < 0.00001)、降低COPD患者全因死亡风险(RR = 0.23, 95% CI = 0.14~0.38, P < 0.00001)。结论:23价肺炎球菌多糖疫苗与流感疫苗的联合接种对于减少COPD患者的急性发作次数、降低死亡风险、缩短住院天数有着积极作用;但是由于方法学原因及文献质量高低不一,需要更多科学、严谨、质量高的研究验证疫苗联合接种效果。
Objective: To compare the clinical prevention and treatment effects of 23 valent pneumococcal pol-ysaccharide vaccine combined with influenza vaccine and routine treatment on patients with chronic obstructive pulmonary disease (COPD). Methods: Related literatures were read from Chi-nese and English databases from the establishment time of each database to June 2022. The litera-tures were screened and extracted according to inclusion and exclusion criteria, and the literature quality was evaluated. RevMan5.4 software was used for analysis. Results: A total of 1416 subjects were included in 12 studies, including 699 in the intervention group and 717 in the control group. Meta-analysis showed that 23-valent pneumococcal vaccine combined with influenza vaccine re-duced the average length of hospital stay in COPD patients (WMD = ?4.35, 95% CI = ?4.50 to ?4.21, P < 0.00001), reduced the number of COPD acute (WMD = ?4.31, 95% CI = ?4.46~?4.17, P < 0.00001), reduced the risk of all-cause death in COPD patients (RR = 0.23, 95% CI = 0.14~0.38, P < 0.00001). Conclusion: The combined administration of 23 valent pneumococcal polysaccharide vac-cine and influenza vaccine has a positive effect on reducing the number of acute episodes in COPD patients, reducing the risk of death and shortening the length of hospital stay; However, due to methodological reasons and different literature quality, more scientific and rigorous high-quality studies are needed to verify the effect of combined vaccination.
%K 23价肺炎球菌多糖疫苗,流感疫苗,慢性阻塞性肺疾病,Meta分析
23-Valent Pneumococcal Polysaccharide Vaccine
%K Influenza Vaccine
%K Chronic Obstructive
Pulmonary Disease
%K Meta Analysis
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=53851